Adalimumab improves sleep and sleep quality in patients with active ankylosing spondylitis

Journal of Rheumatology

Volumn 38, Issue 1, 2011, Pages 79-86

  Rudwaleit, Martin ^a   Gooch, Katherine ^b   Michel, Beat ^c   Herold, Manfred ^d   Thörner, Åke ^e   Wong, Robert ^b   Kron, Martina ^f   Chen, Naijun ^b   Kupper, Hartmut ^f  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ABBOTT LABORATORIES   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^e Mälasjukhuset Eskilstuna ^*  (Sweden)

^f ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Adalimumab; Ankylosing spondylitis; Clinical trial; Fatigue; Outcome assessment; Pain; Quality of life; Sleep

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTHRALGIA; ARTICLE; BACKACHE; CONTROLLED CLINICAL TRIAL; DISEASE ACTIVITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; MULTICENTER STUDY; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUESTIONNAIRE; SHORT FORM 36; SLEEP; SLEEP DEPRIVATION; SLEEP PATTERN; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FATIGUE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SLEEP; SLEEP DISORDERS; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 78650917472     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100213     Document Type: Article

References (36)

1. Sieper J, Rudwaleit M, Khan MA, Braun J. Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol 2006;20:401-17.
2. Boonen A, van der Linden SM. The burden of ankylosing spondylitis. J Rheumatol 2006;33 Suppl 78:4-11.
3. Ward MM. Health-related quality of life in ankylosing spondylitis: a survey in 175 patients. Arthritis Care Res 1999;12:247-55.
4. Hutchings A, Calloway M, Choy E, Hooper M, Hunter DJ, Jordan JM, et al. The Longitudinal Examination of Arthritis Pain (LEAP) study: relationships between weekly fluctuations in patient-rated joint pain and other health outcomes. J Rheumatol 2007;34:2291-300.
5. Mengshoel AM, Forre O. Pain and fatigue in patients with rheumatic disorders. Clin Rheumatol 1993;12:515-21.
6. Ward MM. Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum 2002;46:223-31.
7. Jamieson AH, Alford CA, Bird HA, Hindmarch I, Wright V. The effect of sleep and nocturnal movement on stiffness, pain, and psychomotor performance in ankylosing spondylitis. Clin Exp Rheumatol 1995;13:73-8.
8. Revicki DA, Luo MP, van der Heijde DMF, Wong RL, Chen N, Davis JC; ATLAS Study Group. Adalimumab reduces pain, fatigue and stiffness in patients with ankylosing spondylitis: results from the Adalimumab Trial Evaluating Long-Term Safety and Efficacy for Ankylosing Spondylitis (ATLAS). J Rheumatol 2008;35:1346-53.
9. Van der Horst-Bruinsma IE, Clegg DO, Dijkmans BAC. Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs. Clin Exp Rheumatol 2002;20 Suppl 28:S67-70.
10. Hultgren S, Broman JE, Gudbjornsson B, Hetta J, Lindqvist U. Sleep disturbances in outpatients with ankylosing spondylitis: a questionnaire study with gender implications. Scand J Rheumatol 2000;29:365-9.
11. Zamarron C, Maceiras F, Mera A, Gomez-Reino JJ. Effect of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis. Ann Rheumatic Dis 2004:63:88-90.
12. Winkler V. Sulfasalazine therapy in spondylarthritis ankylpoietica. Orvosi Hetilap 1989;130:77-81.
13. Taylor HG, Beswick EJ, Dawes PT. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment. Clin Rheumatol 1991;10:43-8.
14. Hays RD, Stewart AL. Measuring functioning and well-being: The Medical Outcomes Study approach. In: Stewart AL, Ware JE, editors. Sleep measures. Durham: Duke University Press; 1992:235-59.
15. Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 2005;6:41-4.
16. Rejas J, Ribera MV, Ruiz M, Masrramon X. Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain. Eur J Pain 2007;11:329-40.
17. Wolfe F, Michaud K, Li T. Sleep disturbance in patients with rheumatoid arthritis: evaluation by Medical Outcomes Study and visual analog sleep scales. J Rheumatol 2006;33:1942-51.
18. Rudwaleit M, Claudepierre P, Wordsworth P, Loza Cortina E, Sieper J, Kron M, et al. Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis. J Rheumatol 2009;36:801-8.
19. Rudwaleit M, Rødevand E, Holck P, Vanhoof J, Kron M, Kary S, et al. Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis 2009;68:696-701.
20. Rudwaleit M, Olivieri I, Boki KA, Griep EN, Järvinen P, Wong RL, et al. Adalimumab is effective and well tolerated in treating patientswith ankylosing spondylitis who have advanced spinal fusion. Rheumatology 2009;48:551-7.
21. van der Heijde D, Dougados M, Davis J, Weisman MH, Maksymowych W, Braun J, et al. Assessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis. Arthritis Rheum 2005;52:386-94.
22. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
23. Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics 2004;22:225-44.
24. Braun J, van der Heijde D, Dougados M, Emery P, Khan MA, Sieper J, et al. Staging of patients with ankylosing spondylitis: a preliminary proposal. Ann Rheum Dis 2002;61 Suppl III:19-23.
25. Rowntree D. Analyzing relationships - interpreting a correlation coefficient. In: Statistics without tears. 2nd ed. Boston: Pearson; 2004:169-76.
26. Cohen J. Statistical power analyses for the behavioral sciences. 2nd ed. Hillsdale: Erlbaum; 1988.
27. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000;53:459-68.
28. van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BAC, Braun J, et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006;54:1063-74.
29. Wells G, Li T, Maxwell L, Maclean R, Tugwell P. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis 2008;67:260-5.
30. Wells G, Li T, Maxwell L, Maclean R, Tugwell P. Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis. J Rheumatol 2007;34:280-9.
31. de la Loge C, Viala M. Psychometric properties of the MOS-sleep using international clinical trial data. Qual Life Res 2003;12:826.
32. Cole JC, Dubois D, Kosinski M. Use of patient reported sleep measures in clinical trials of pain treatment: a literature review and synthesis of current sleep measures and a conceptual model of sleep disturbance in pain. Clin Ther 2007;29:2580-8.
33. Solak O, Fidan F, Dündar U, Türel A, Ayçiçek A, Kavuncu V, et al. The prevalence of obstructive sleep apnoea syndrome in ankylosing spondylitis patients. Rheumatology 2009;48:433-5.
34. Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E. Correlates of serum C-reactive protein (CRP): no association with sleep duration of sleep disordered breathing. Sleep 2007;30:991-6.
35. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004;43:678-83.
36. Haack M, Mullington JM. Sustained sleep restriction reduces emotional and physical well-being. Pain 2005;119:56-64.